Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
09:42:49 EDT Sun 27 Jul 2025
Enter Symbol
or Name
USA
CA



Q:ELTP - ELITE PHARMACEUTICALS INC - https://www.elitepharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ELTP - Qnot subscribed0.5519+0.00991.8527.72791710.5453  0.552  0.5250.8194  0.162615:58:26Jun 3015 min RT 2¢

Recent Trades - Last 10 of 171
Time ETExPriceChangeVolume
15:58:26Q0.5476250.0056251
15:54:11Q0.55190.00991,200
15:54:08Q0.5406-0.00141,000
15:54:06Q0.5407-0.00135,516
15:54:04Q0.5407-0.00134,095
15:52:12Q0.54-0.0021,000
15:51:59Q0.54-0.002500
15:51:57Q0.54-0.002100
15:51:55Q0.54-0.0021,000
15:51:53Q0.54-0.00223,200

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-06-30 16:15U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2025 and Provides Conference Call Information
2025-06-23 07:01U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2025 Financial Results on July 1, 2025
2025-06-16 07:01U:ELTPNews ReleaseElite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
2025-04-30 16:31U:ELTPNews ReleaseElite Pharmaceuticals Announces Commercial Launch of Oxycodone and Acetaminophen Tablets
2025-03-03 07:01U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Announces First Shipment of Product from New Facility and Packaging Line
2025-02-13 16:23U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2025 ended December 31, 2024 and Provides Conference Call Information
2025-02-10 16:55U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2025 Financial Results on February 14, 2025
2024-12-26 07:01U:ELTPNews ReleaseElite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R)
2024-12-02 06:01U:ELTPNews ReleaseElite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Hydrocodone Tablets
2024-11-18 06:01U:ELTPNews ReleaseElite Pharmaceuticals Receives FDA Approval for Generic Vyvanse
2024-11-14 16:39U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information
2024-11-07 07:02U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2025 Financial Results on November 15, 2024
2024-10-10 16:42U:ELTPNews ReleaseElite Pharmaceuticals' Generic Adderall(R) Receives Marketing Approval from the Israeli Ministry of Health
2024-10-07 07:31U:ELTPNews ReleaseElite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Codeine Phosphate Tablets
2024-08-27 07:01U:ELTPNews ReleaseElite Pharmaceuticals Announces Commercial Launch of Generic Methotrexate Sodium
2024-08-14 17:10U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2025 Ended June 30, 2024 and Provides Conference Call Information
2024-08-09 16:01U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2025 Financial Results on August 15, 2024